ArticleJournal of nanobiotechnology2025
An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Glycolytic reprogramming in endometriosis: molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities.BMC women's health · 2026Review
- Multicomponent Ganoderma lucidum spore-based solid self-nanoemulsifying system of paclitaxel for improved lymphatic absorption and immune synergistic antitumor strategy.Journal of nanobiotechnology · 2026Article
- Lactylation in cancer: molecular mechanisms and advances in clinical study.Molecular cancer · 2026Review
- From Barrier to Gateway: Nanomaterials Reshaping the Tumor Microenvironment for Therapy.International journal of nanomedicine · 2026Review
- Organic Sonosensitizers-based SDT with enhanced ROS generation.Ultrasonics sonochemistry · 2025Review
- Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.Molecular cancer · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lactate is an immunosuppressive molecule that plays an important role in tumor progression. Regulating lactate metabolism to remodel the immunosuppressive microenvironment represents a promising strategy for cancer therapy. However, owing to the hypoxic nature of the tumor microenvironment and single intervention strategies, the effect of lactate oxidase for cancer therapy is not as expected. Therefore, we engineered a self-oxygen-generating nanoplatform by encapsulating lactate oxidase and manganese porphyrin within nanoliposomes (ML@Lip). Lactate depletion via lactate oxidase promoted the polarization of tumor-associated macrophages toward the M1 phenotype in the tumor microenvironment and modulated innate antitumor immunity. Manganese porphyrin-mediated sonodynamic therapy induced not only tumor cell apoptosis but also immunogenic cell death. The release of damage-associated molecular patterns promoted dendritic cell maturation and T-cell activation, leading to immune system activation and the initiation of adaptive immunity. Additionally, manganese catalyzed the decomposition of hydrogen peroxide (derived from lactate breakdown) to generate substantial oxygen. This process established a positive feedback loop via lactate depletion while amplifying sonodynamic therapeutic effects through enhanced oxygen production. Therefore, the strategy of combining lactate depletion-induced starvation therapy, sonodynamic therapy and self-circulating oxygen generation effectively remodeled the immunosuppressive tumor microenvironment and inhibited tumor growth, thereby providing novel insights into targeted lactate metabolism therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.